Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 2739014, 9 pages
https://doi.org/10.1155/2018/2739014
Review Article

The Relationship between Serum Zinc Level and Heart Failure: A Meta-Analysis

1Department of Cardiology, Tianjin Medical University General Hospital, Tianjin 300070, China
2Department of Cardiology, Tianjin Union Medical Center, Tianjin 300121, China

Correspondence should be addressed to Bo Bian; moc.361@yyzobnaib

Received 8 November 2017; Revised 15 January 2018; Accepted 24 January 2018; Published 25 February 2018

Academic Editor: Swaran J. S. Flora

Copyright © 2018 Xuefang Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Berg and Y. Shi, “The galvanization of biology: a growing appreciation for the roles of zinc,” Science, vol. 271, no. 5252, pp. 1081–1085, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. C. T. Chasapis, A. C. Loutsidou, C. A. Spiliopoulou, and M. E. Stefanidou, “Zinc and human health: an update,” Archives of Toxicology, vol. 86, no. 4, pp. 521–534, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. S. Prasad, “Discovery of human zinc deficiency: Its impact on human health and disease,” Advances in Nutrition, vol. 4, no. 2, pp. 176–190, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Little, R. Bhattacharya, A. E. Moreyra, and I. L. Korichneva, “Zinc and cardiovascular disease,” Nutrition Journal , vol. 26, no. 11-12, pp. 1050–1057, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Foster and S. Samman, “Zinc and redox signaling: Perturbations associated with cardiovascular disease and diabetes mellitus,” Antioxidants & Redox Signaling, vol. 13, no. 10, pp. 1549–1573, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Xu and J. Zhou, “Zinc and myocardial ischemia/reperfusion injury,” BioMetals, vol. 26, no. 6, pp. 863–878, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. K. T. Weber, W. B. Weglicki, and R. U. Simpson, “Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium,” Cardiovascular Research, vol. 81, no. 3, pp. 500–508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. F. Sullivan, A. J. Blotcky, M. M. Jetton, H. K. Hahn, and R. E. Burch, “Serum levels of selenium, calcium, copper magnesium, manganese and zinc in various human diseases,” Journal of Nutrition, vol. 109, no. 8, pp. 1432–1437, 1979. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Atlihan, T. Soylemezoglu, A. Gokce, G. Guvendik, and O. Satici, “Zinc and copper in congestive heart failure,” Turkish Journal of Pediatrics, vol. 32, pp. 33–38, 1990. View at Google Scholar
  10. O. Oster, “Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy,” Clinica Chimica Acta, vol. 214, no. 2, pp. 209–218, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Cénac, M. Simonoff, and A. Djibo, “Nutritional status and plasma trace elements in peripartum cardiomyopathy. A comparative study in Niger,” Journal of Cardiovascular Risk, vol. 3, no. 6, pp. 483–487, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. M. De Lorgeril, P. Salen, M. Accominotti et al., “Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure,” European Journal of Heart Failure, vol. 3, no. 6, pp. 661–669, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Topuzoglu, A. R. Erbay, A. B. Karul, and N. Yensel, “Concentations of Copper, Zinc, and Magnesium in Sera from Patients with Idiopathic Dilated Cardiomyopathy,” Biological Trace Element Research, vol. 95, no. 1, pp. 11–17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Kosar, I. Sahin, C. Taskapan et al., “Trace element status (Se, Zn, Cu) in heart failure,” Anadolu Kardiyol Derg 6, pp. 216–220, 2006. View at Google Scholar
  15. A. Ghaemian, E. Salehifar, R. Jalalian et al., “Zinc and copper levels in severe heart failure and the effects of atrial fibrillation on the zinc and copper status,” Biological Trace Element Research, vol. 143, no. 3, pp. 1239–1246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Alexanian, J. Parissis, D. Farmakis et al., “Clinical and echocardiographic correlates of serum copper and zinc in acute and chronic heart failure,” Clinical Research in Cardiology, vol. 103, no. 11, pp. 938–949, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Golik, N. Cohen, Y. Ramot et al., “Type II diabetes mellitus, congestive heart failure, and zinc metabolism,” Biological Trace Element Research, vol. 39, no. 2-3, pp. 171–175, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Salehifar, M. Shokrzadeh, A. Ghaemian, S. Aliakbari, and S. S. Saeedi Saravi, “The study of Cu and Zn serum levels in idiopathic dilated cardiomyopathy (IDCMP) patients and its comparison with healthy volunteers,” Biological Trace Element Research, vol. 125, no. 2, pp. 97–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Shokrzadeh, A. Ghaemian, E. Salehifar, S. Aliakbari, S. S. S. Saravi, and P. Ebrahimi, “Serum zinc and copper levels in ischemic cardiomyopathy,” Biological Trace Element Research, vol. 127, no. 2, pp. 116–123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. B. Milne, C. D. Davis, and F. H. Nielsen, “Low dietary zinc alters indices of copper function and status in postmenopausal women,” Nutrition Journal , vol. 17, no. 9, pp. 701–708, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Zoli, L. Altomonte, R. Caricchio et al., “Serum zinc and copper in active rheumatoid arthritis: Correlation with interleukin 1β and tumour necrosis factor α,” Clinical Rheumatology, vol. 17, no. 5, pp. 378–382, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Kucharzewski, J. Braziewicz, U. Majewska, and S. Góźdź, “Copper, zinc, and selenium in whole blood and thyroid tissue of people with various thyroid diseases,” Biological Trace Element Research, vol. 93, no. 1-3, pp. 9–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Mezzetti, S. D. Pierdomenico, F. Costantini et al., “Copper/zinc ratio and systemic oxidant load: Effect of aging and aging- related degenerative diseases,” Free Radical Biology & Medicine, vol. 25, no. 6, pp. 676–681, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. J. R. Wu, D. K. Moser, D. A. Dewalt, M. K. Rayens, and K. Dracup, “Health Literacy Mediates the Relationship between Age and Health Outcomes in Patients with Heart Failure,” Circulation: Heart Failure, vol. 9, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Belbraouet, H. Biaudet, A. Tébi, N. Chau, K. Gray-Donald, and G. Debry, “Serum Zinc and Copper Status in Hospitalized vs. Healthy Elderly Subjects,” Journal of the American College of Nutrition, vol. 26, no. 6, pp. 650–654, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Malavolta, F. Piacenza, A. Basso, R. Giacconi, L. Costarelli, and E. Mocchegiani, “Serum copper to zinc ratio: Relationship with aging and health status,” Mechanisms of Ageing and Development, vol. 151, pp. 93–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ruz, K. R. Cavan, W. J. Bettger, P. W. F. Fischer, and R. S. Gibson, “Indices of iron and copper status during experimentally induced, marginal zinc deficiency in humans,” Biological Trace Element Research, vol. 34, no. 2, pp. 197–212, 1992. View at Publisher · View at Google Scholar · View at Scopus
  28. S. R. Powell, “The Antioxidant Properties of Zinc,” Journal of Nutrition, vol. 130, no. 5, pp. 1447S–1454S, 2000. View at Publisher · View at Google Scholar
  29. Z. Ungvári, S. A. Gupte, F. A. Recchia, S. Bátkai, and P. Pacher, “Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure,” Current Vascular Pharmacology, vol. 3, no. 3, pp. 221–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Wykretowicz, J. Furmaniuk, J. Smielecki et al., “The oxygen stress index and levels of circulating interleukin-10 and interleukin-6 in patients with chronic heart failure,” International Journal of Cardiology, vol. 94, no. 2-3, pp. 283–287, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Demirbag, R. Yilmaz, O. Erel, U. Gultekin, D. Asci, and Z. Elbasan, “The relationship between potency of oxidative stress and severity of dilated cardiomyopathy,” Canadian Journal of Cardiology, vol. 21, no. 10, pp. 851–855, 2005. View at Google Scholar · View at Scopus
  32. H. Takano, Y. Zou, H. Hasegawa, H. Akazawa, T. Nagai, and I. Komuro, “Oxidative Stress-Induced Signal Transduction Pathways in Cardiac Myocytes: Involvement of ROS in Heart Diseases,” Antioxidants & Redox Signaling, vol. 5, no. 6, pp. 789–794, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Itoh, S. Oh-Ishi, H. Hatao et al., “Effects of dietary calcium restriction and acute exercise on the antioxidant enzyme system and oxidative stress in rat diaphragm,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 287, no. 1, pp. R33–R38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Tousoulis, N. Papageorgiou, A. Briasoulis, C. Antoniades, and C. Stefanadis, “The failure of immunomodulation therapy in heart failure: Does the statins "paradigm" prove the rule?” Current Vascular Pharmacology, vol. 8, no. 1, pp. 114–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Mocchegiani, M. Muzzioli, C. Cipriano, and R. Giacconi, “Zinc, T-cell pathways, aging: Role of metallothioneins,” Mechanisms of Ageing and Development, vol. 106, no. 1-2, pp. 183–204, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Efeovbokhan, S. K. Bhattacharya, R. A. Ahokas et al., “Zinc and the prooxidant heart failure phenotype,” Journal of Cardiovascular Pharmacology, vol. 64, no. 4, pp. 393–400, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Cohen and A. Golik, “Zinc balance and medications commonly used in the management of heart failure,” Heart Failure Reviews, vol. 11, no. 1, pp. 19–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. H. I. Afridi, T. G. Kazi, N. Kazi et al., “Distribution of copper, iron, and zinc in biological samples of Pakistani hypertensive patients and referent subjects of different age groups,” Clinical Laboratory, vol. 59, no. 9-10, pp. 959–967, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. B. G. Childs, D. J. Baker, T. Wijshake, C. A. Conover, J. Campisi, and J. M. Van Deursen, “Senescent intimal foam cells are deleterious at all stages of atherosclerosis,” Science, vol. 354, no. 6311, pp. 472–477, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. A. B. Gevaert, H. Shakeri, A. J. Leloup et al., “Endothelial Senescence Contributes to Heart Failure with Preserved Ejection Fraction in an Aging Mouse Model,” Circulation: Heart Failure, vol. 10, no. 6, Article ID e003806, 2017. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Malavolta, L. Costarelli, R. Giacconi et al., “Changes in Zn homeostasis during long term culture of primary endothelial cells and effects of Zn on endothelial cell senescence,” Experimental Gerontology, vol. 99, pp. 35–45, 2017. View at Publisher · View at Google Scholar · View at Scopus